CCNG1 (Cyclin G1) showed an up-regulation significant in the endometrial cancer patient group (Fig 6B) at the early time-points of 24 hr and 48 hr while in the head and neck cancer patients we detected up-regulations that were not statistically significant (Fig 7B). The gene discussed is CCNG1; the disease is endometrial cancer.